The subject of the contract is the successive delivery of medicines as part of the Therapeutic Drug Programs. The subject of the order was divided into packages according to the assortment. Detailed parameters regarding the subject of the contract (description of the subject of the contract, estimated quantity) are set out in Annex 2a÷g to the SWZ.
Package No. 1Botulinum toxin type A. Detailed parameters regarding the subject of the contract (description of the subject of the contract, estimated quantities) are set out in Annex 2a to the SWZ.
Package No. 2Adalimumab 40 mg. Detailed parameters regarding the subject of the contract (description of the subject of the contract, estimated quantity) are set out in Annex 2b to the SWZ.
Package No. 3Adalimumab 20mg. Detailed parameters regarding the subject of the contract (description of the subject of the contract, estimated quantity) are set out in Annex 2c to the SWZ.
Package No. 4Etanercept 25 mg. Detailed parameters regarding the subject of the contract (description of the subject of the contract, estimated quantity) are specified in Annex 2d to the SWZ.
Package number 5Omalizumab 150 mg. Detailed parameters regarding the subject of the contract (description of the subject of the contract, estimated quantity) are specified in Annex 2e to the SWZ.
Package number 6Tocilizumab. Detailed parameters regarding the subject of the contract (description of the subject of the contract, estimated quantity) are specified in Annex 2f to the SWZ.
Package No. 7Etanercept 50 mg. Detailed parameters regarding the subject of the contract (description of the subject of the contract, estimated quantity) are specified in Annex 2g to the SWZ.